SUZHOU, China, Oct. 25, 2024 /PRNewswire/ -- Recently, NeoMab Biotechnology (Suzhou) Co., Ltd. (referred to as "NeoMab") launched the innovative NeoMab-IgG Ease model, based on its next-generation fully human antibody transgenic mouse model—NeoMab. This advancement marks another...
NeoMab Fully Human Antibody Discovery Platform: A New Flexible Mouse Purchase Model Leading a New Trend in Antibody Drug Development
Seaking AlphaSeeking Alpha / Seaking Alpha 9 hours ago 1 Views
Comments